A mysterious hematochezia in an adolescent boy: atypical presentation of childhood systemic lupus erythematosus





SLE, LAHS, Hypoprothrombinemia, Lupus anticoagulant, Bleeding


Thrombosis is a well-known entity in presence of antiphospholipid antibody (APLA) associated with systemic lupus erythematosus (SLE) as a hematological complication. Bleeding manifestations instead of thrombosis is hardly found in literature in presence of APLA seromarkers in SLE. Since these can range from minor bleeding like epistaxis to major life-threatening intracranial bleeding, early diagnosis and prompt treatment is essential to manage such condition. We report a 12 years old boy with no significant past history presented with hematochezia and epistaxis along with pallor requiring blood transfusion. Hematological investigations were normal except for elevated PT, aPTT and INR. Common causes of coagulopathy were ruled out. Upon suspecting systemic diseases, the investigations were carried out which revealed ANA 4+ along with high titre of dsDNA, low C3 and C4 complement and positive anti-β2 glycoprotein, anticardiolipin antibody and lupus anticoagulant. Diagnosis of SLE was made according to ACR-EULAR criteria with no renal involvement. Immunological basis was considered for coagulopathy in this child. He was started on oral prednisolone, hydroxychloroquine and methotrexate. He is now under close monitoring of the coagulation profile for titration of steroid dose. We want to create awareness about the uncommon hematological manifestation of SLE presenting as bleeding diathesis instead of thrombosis through this case report and that can be life threatening too if not treated promptly. A high index of suspicion and careful follow-up may help in preventing adverse outcome of the disease.



Broussard-Perry D, Heiner DC, Robinson L, Anand S. Bleeding as the Initial Manifestation of Systemic Lupus Erythematosus. Pediatric Asthma Allergy Immunol. 1994;233-8.

Eberhard A, Sparling C, Sudbury S, Ford P, Laxer R, Silverman E. Hypoprothrombinemia in childhood systemic lupus erythematosus. Semin Arthritis Rheum. 1994;24(1):12-8.

Pilania RK, Suri D, Jindal AK, Kumar N, Sharma A, Sharma P, et al. Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature. Rheumatol Int. 2018;38(10):1933-40.

Bhowmick R, Agarwal I, Arumugam V, Kumar T S. Lupus Anticoagulant-Hypoprothrombinemia Syndrome. Indian J Pediatr. 2018;85(5):392-3.

Kubisz P, Holly P, Stasko J. Bleeding in Patients with Antiphospholipid Antibodies [Internet]. Antiphospholipid Syndrome - Recent Advances in Clinical and Basic Aspects. IntechOpen. 2022.

Punnen KA, Kumar TS, Geevar T. Lupus Cofactor Phenomenon in a Child with Systemic Lupus Erythematosus with Lupus Anticoagulant-Hypoprothrombinemia Syndrome. J Indian Rheumatol Assoc. 2021;16(4):466-8.

Kim JS, Kim MJ, Bae EY, Jeong DC. Pulmonary hemorrhage in pediatric lupus anticoagulant hypoprothrombinemia syndrome. Korean J Pediatr. 2014;57(4):202-5.

Favier R, Kheyar T, Renolleau S, Tabone MD, Favier M, Ulinski T. Syndrome Lupus anticoagulant-hypoprothrombinemia syndrome revealing systemic lupus in an 11-year old girl in a context of clinical and biological emergency. Ann Biol Clin (Paris). 2012;70(2):226-30.

Yacobovich JR, Uziel Y, Friedman Z, Radnay J, Wolach B. Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome. Rheumatology (Oxford). 2001;40(5):585-7.






Case Reports